sars-cov-2 - Globe Thesis

Keyword [sars-cov-2] Result: 41 - 60 \| Page: 3 of 10
41.	Design And Study Of Small Molecule Inhibitors Of SARS-CoV-2 Mpro,PLpro
42.	Screening Of SARS-CoV-2 Spike Protein Inhibitors Based On HACE2 Binding Feature
43.	Characterization Of Pangolin Coronavirus GX＿P2V And Study On New Drugs Against Coronavirus
44.	High Expression Of Neutralizing Nanobodies Against SARS-CoV-2 In Pichia Pastoris
45.	Inhibition Of SARS-CoV-2 Infection Through Extracellular Vesicles And The Effect Of Curcumin On Extracellular Vesicles
46.	Effects And Underlying Mechanism Of Traditional Chinese Medicine Against COVID-19 Based On Nrf2-ACE2 Signaling Pathway
47.	An Elementary Study On Recombinant Attenuated Strain Of SARS-CoV-2S Protein RBD Based On Influenza Viral Vector
48.	Application Of DNA Immunization In The Preparation Of Secondary Antibodies And Immunogen Evaluation Of Tree Shrews
49.	Research On The Establishment Of SARS-CoV-2 Pseudovirus System And Vaccine Preliminary Evaluation
50.	Comparative Study On The Immunoge Nicity Of SARS-CoV-2 NP,RBD And Their Fusion FlaB Proteins
51.	Humanized Modification And Identification Of Murine Monoclonal Antibody Against SARS-CoV-2
52.	Construction And Applications Of The SARS-CoV-2 Pseudovirus
53.	The Mutual Regulation And Mechanism Of SARS-CoV-2 And Innate Immunity
54.	The Design And Immunogenicity Of SARS-CoV-2 RBD Recombination Protein Vaccine And Peptide Vaccine
55.	Investigation Of AIM2 Inflammasome In EV71 Induced Encephalitis And Studies On The Baculovirus As The Live Virus Vaccine Vector Of SARS-CoV-2
56.	Preparation Of SARS-CoV-2 RBD Protein Specific Humanized Neutralizing Monoclonal Antibodies
57.	Construction And Experimental Immunization Research Of Severe Acute Respiratory Syndrome Coronavirus 2 Bacterium-like Particles Vaccine
58.	Research On Mechanism Of A Specific AB 82A6 Neutralized SARS-CoV-2 Via S1 Shedding
59.	Evaluation Of Safety,immunogenicity And Alternative Methods For Antibody Detection Of An Inactivated SARS-CoV-2 Vaccine In Healthy Adults Aged 18-59 Years
60.	Development Of Two Egg Yolk Antibodies Against SARS-CoV-2 Nucleocapsid Protein And Spike Protein S1 Subunit In Chicken
<<First <Prev Next> Last>> Jump to